当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Bactrim Suspension and Bactrim Pediatric Suspension
通用名称
sulfamethoxazole/trimethoprim
儿科标签批准日期
2020/7/28 0:00:00
特定指示/秒
Postmarketing study
标签更改摘要
- A simulation conducted with data from a pharmacokinetic study in 153 infants and children demonstrated that mean steady state AUC and maximum plasma concentration of trimethoprim and sulfamethoxazole would be comparable between pediatric patients 2 months to 18 years receiving 8/40 (trimethoprim/ sulfamethoxazole) mg/kg/day divided every 12 hours and adult patients receiving 320/1600 (trimethoprim/ sulfamethoxazole) mg/day.
- Postmarketing study.
- Off-patent Written Request.